These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26610471)

  • 1. Biodistribution, Stability, and Blood Distribution of the Cell Penetrating Peptide Maurocalcine in Mice.
    Perret P; Ahmadi M; Riou L; Bacot S; Pecher J; Poillot C; Broisat A; Ghezzi C; De Waard M
    Int J Mol Sci; 2015 Nov; 16(11):27730-40. PubMed ID: 26610471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative evaluation of the cell penetrating properties of an iodinated Tyr-L-maurocalcine analog.
    Tisseyre C; Ahmadi M; Bacot S; Dardevet L; Perret P; Ronjat M; Fagret D; Usson Y; Ghezzi C; De Waard M
    Biochim Biophys Acta; 2014 Oct; 1843(10):2356-64. PubMed ID: 24667409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small efficient cell-penetrating peptides derived from scorpion toxin maurocalcine.
    Poillot C; Bichraoui H; Tisseyre C; Bahemberae E; Andreotti N; Sabatier JM; Ronjat M; De Waard M
    J Biol Chem; 2012 May; 287(21):17331-17342. PubMed ID: 22433862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced and selective permeability of gold nanoparticles functionalized with cell penetrating peptide derived from maurocalcine animal toxin.
    Khamehchian S; Nikkhah M; Madani R; Hosseinkhani S
    J Biomed Mater Res A; 2016 Nov; 104(11):2693-700. PubMed ID: 27324825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell penetration properties of maurocalcine, a natural venom peptide active on the intracellular ryanodine receptor.
    Boisseau S; Mabrouk K; Ram N; Garmy N; Collin V; Tadmouri A; Mikati M; Sabatier JM; Ronjat M; Fantini J; De Waard M
    Biochim Biophys Acta; 2006 Mar; 1758(3):308-19. PubMed ID: 16545341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution of the cyclotide MCoTI-II, a cyclic disulfide-rich peptide drug scaffold.
    Wang CK; Stalmans S; De Spiegeleer B; Craik DJ
    J Pept Sci; 2016 May; 22(5):305-10. PubMed ID: 26929247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transduction of the scorpion toxin maurocalcine into cells. Evidence that the toxin crosses the plasma membrane.
    Estève E; Mabrouk K; Dupuis A; Smida-Rezgui S; Altafaj X; Grunwald D; Platel JC; Andreotti N; Marty I; Sabatier JM; Ronjat M; De Waard M
    J Biol Chem; 2005 Apr; 280(13):12833-9. PubMed ID: 15653689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical amino acid residues of maurocalcine involved in pharmacology, lipid interaction and cell penetration.
    Mabrouk K; Ram N; Boisseau S; Strappazzon F; Rehaim A; Sadoul R; Darbon H; Ronjat M; De Waard M
    Biochim Biophys Acta; 2007 Oct; 1768(10):2528-40. PubMed ID: 17888395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of cell-penetrating peptides.
    Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
    Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-Maurocalcine, a pharmacologically inert efficient cell-penetrating peptide analogue.
    Poillot C; Dridi K; Bichraoui H; Pêcher J; Alphonse S; Douzi B; Ronjat M; Darbon H; De Waard M
    J Biol Chem; 2010 Oct; 285(44):34168-80. PubMed ID: 20610396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potential of cell penetrating peptides for cell drug delivery].
    Poillot C; De Waard M
    Med Sci (Paris); 2011 May; 27(5):527-34. PubMed ID: 21609675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (18)F-Labeled phosphopeptide-cell-penetrating peptide dimers with enhanced cell uptake properties in human cancer cells.
    Richter S; Bouvet V; Wuest M; Bergmann R; Steinbach J; Pietzsch J; Neundorf I; Wuest F
    Nucl Med Biol; 2012 Nov; 39(8):1202-12. PubMed ID: 22784382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to stabilize cell penetrating peptides for in vivo applications.
    Fominaya J; Bravo J; Rebollo A
    Ther Deliv; 2015; 6(10):1171-94. PubMed ID: 26448473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-penetrating peptides and peptide nucleic acid-coupled MRI contrast agents: evaluation of cellular delivery and target binding.
    Mishra R; Su W; Pohmann R; Pfeuffer J; Sauer MG; Ugurbil K; Engelmann J
    Bioconjug Chem; 2009 Oct; 20(10):1860-8. PubMed ID: 19788302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a disulfide-less, pharmacologically inert, and chemically competent analog of maurocalcine for the efficient transport of impermeant compounds into cells.
    Ram N; Weiss N; Texier-Nogues I; Aroui S; Andreotti N; Pirollet F; Ronjat M; Sabatier JM; Darbon H; Jacquemond V; De Waard M
    J Biol Chem; 2008 Oct; 283(40):27048-56. PubMed ID: 18621738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular uptake and in vivo distribution of polyhistidine peptides.
    Iwasaki T; Tokuda Y; Kotake A; Okada H; Takeda S; Kawano T; Nakayama Y
    J Control Release; 2015 Jul; 210():115-24. PubMed ID: 25980622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced serum proteolysis resistance of cell-penetrating peptides.
    Fominaya J; Bravo J; Decaudin D; Brossa JY; Nemati F; Rebollo A
    Ther Deliv; 2015 Feb; 6(2):139-47. PubMed ID: 25690083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: Biodistribution and transfection.
    Sharma G; Modgil A; Layek B; Arora K; Sun C; Law B; Singh J
    J Control Release; 2013 Apr; 167(1):1-10. PubMed ID: 23352910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor efficacy, pharmacokinetic and biodistribution studies of the anticancer peptide CIGB-552 in mouse models.
    Vallespí MG; Pimentel G; Cabrales-Rico A; Garza J; Oliva B; Mendoza O; Gomez Y; Basaco T; Sánchez I; Calderón C; Rodriguez JC; Markelova MR; Fichtner I; Astrada S; Bollati-Fogolín M; Garay HE; Reyes O
    J Pept Sci; 2014 Nov; 20(11):850-9. PubMed ID: 25044757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative variability in the biodistribution and in toxinokinetic studies of the three main alpha toxins from the Androctonus australis hector scorpion venom.
    Devaux C; Jouirou B; Naceur Krifi M; Clot-Faybesse O; El Ayeb M; Rochat H
    Toxicon; 2004 May; 43(6):661-9. PubMed ID: 15109887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.